500 mcg Dose: Draw 10 units (0.1 mL)
The temporal pattern typically follows a predictable course: Weeks 0-20: Rapid weight loss phase, with the steepest decline in body weight
Multiple verification steps prevent these outcomes
Many patients stop taking semaglutide within a few months after they start
Among women, the prevalence rose from 8.8% in 1990 to 18.5% in 2022, while in men, it nearly tripled from 4.8% to 14.0% during the same timeframe [4]
However, since eye problems are very rare, it probably would not impact the frequency people on these medications should have their eyes examined. Mir Ali, MD As with all research, finding a greater sample of people affected by these conditions using GLP-1 medications may help to identify risk factors for these types of problems, Ali added